Emerging biomarkers in head and neck cancer in the era of genomics
- PMID: 25403939
- DOI: 10.1038/nrclinonc.2014.192
Emerging biomarkers in head and neck cancer in the era of genomics
Abstract
Head and neck cancer (HNC) broadly includes carcinomas arising from the mucosal epithelia of the head and neck region as well as various cell types of salivary glands and the thyroid. As reflected by the multiple sites and histologies of HNC, the molecular characteristics and clinical outcomes of this disease vary widely. In this Review, we focus on established and emerging biomarkers that are most relevant to nasopharyngeal carcinoma and head and neck squamous-cell carcinoma (HNSCC), which includes primary sites in the oral cavity, oropharynx, hypopharynx and larynx. Applications and limitations of currently established biomarkers are discussed along with examples of successful biomarker development. For emerging biomarkers, preclinical or retrospective data are also described in the context of recently completed comprehensive molecular analyses of HNSCC, which provide a broad genetic landscape and molecular classification beyond histology and clinical characteristics. We will highlight the ongoing effort that will see a shift from prognostic to predictive biomarker development in HNC with the goal of delivering individualized cancer therapy.
Similar articles
-
Cytologic evaluation of cervical lymph node metastases from cancers of unknown primary origin.Semin Diagn Pathol. 2015 Jan;32(1):32-41. doi: 10.1053/j.semdp.2014.12.002. Epub 2014 Dec 20. Semin Diagn Pathol. 2015. PMID: 25618223 Review.
-
Viral-related diseases of the head and neck.Semin Diagn Pathol. 2015 Jan;32(1):1-2. doi: 10.1053/j.semdp.2015.02.020. Epub 2015 Feb 24. Semin Diagn Pathol. 2015. PMID: 25804340 No abstract available.
-
Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17. Hum Pathol. 2016. PMID: 26997438
-
MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.Cancer Biomark. 2015;15(3):213-8. doi: 10.3233/CBM-150464. Cancer Biomark. 2015. PMID: 25769448 Review.
-
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.Clin Epigenetics. 2017 Feb 2;9:12. doi: 10.1186/s13148-017-0317-7. eCollection 2017. Clin Epigenetics. 2017. PMID: 28174607 Free PMC article.
Cited by
-
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.Oncotarget. 2016 Sep 20;7(38):61575-61586. doi: 10.18632/oncotarget.11196. Oncotarget. 2016. PMID: 27528217 Free PMC article.
-
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma.Onco Targets Ther. 2016 May 31;9:3269-80. doi: 10.2147/OTT.S99989. eCollection 2016. Onco Targets Ther. 2016. PMID: 27330306 Free PMC article. Review.
-
An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation.Int J Mol Med. 2020 Oct;46(4):1501-1513. doi: 10.3892/ijmm.2020.4680. Epub 2020 Jul 22. Int J Mol Med. 2020. PMID: 32700748 Free PMC article.
-
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.J Immunother Cancer. 2020 Jul;8(2):e000444. doi: 10.1136/jitc-2019-000444. J Immunother Cancer. 2020. PMID: 32719094 Free PMC article.
-
Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer.Sci Rep. 2019 Oct 23;9(1):15198. doi: 10.1038/s41598-019-51599-7. Sci Rep. 2019. PMID: 31645603 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous